CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «HYDROXYTRYPTAMINE»
Descoperă întrebuințarea
hydroxytryptamine în următoarea selecție bibliografică. Cărți în legătură cu
hydroxytryptamine și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
5-
Hydroxytryptamine Mechanisms in Primary Headaches
Biochemistry & physiology; experimental pharmacology; 5-HT involvement in migraine; drugs affecting 5-HT receptors.
Jes Olesen, Pramod R. Saxena, 1992
2
5-
Hydroxytryptamine-3 Receptor Antagonists
This book will be an important reference for oncologists, researchers working with the CNS and gastrointestinal disorders, and anyone working in the 5-HT field within the pharmaceutical arena, academia, and medical practice.
Francis D. King, Brian J. Jones, Gareth J. Sanger, 1993
3
5-
Hydroxytryptamine in Psychiatry: A Spectrum of Ideas
For example, our understanding of and the treatment for obsessive-compulsive disorder has been transformed in a very few years. This book is the result of a meeting of the Collegium Internationale Neuro-Psychopharmacologicum.
Merton Sandler, Alec Coppen, Sara Harnett, 1991
4
5-
Hydroxytryptamine and Related Indolealkylamines
With contributions by numerous experts
5
The Peripheral actions of 5-
hydroxytryptamine
This book describes the major recent advances in this area, specifically with respect to the actions of 5-HT in the periphery.
6
Current Pharmaceutical Design
5-Hydroxytryptamine. (5-HT)3. Receptors: Molecular. Biology,. Pharmacology.
and. Therapeutic. Importance. R.M.. Eglen*. and. D.W.. Bonhaus. Institute of
Pharmacology, Neurobiology Unit, Roche Bioscience, 3401, Hillview Ave., Palo
Alto, ...
7
Serotonin and Gastrointestinal Function
Biilbring, E. and Lin, R. C. Y., The effect of intraluminal application of 5-
hydroxytryptamine and 5-hydroxytryptophan on peristalsis; the local production of
5-HT and its release in relation to intraluminal pressure and propulsive activity, J.
Physiol.
Timothy S. Gaginella, James J. Galligan, 1995
8
Cockroaches as Models for Neurobiology
TABLE 5 Effect of Receptor Antagonists on 5- Hydroxytryptamine-Mediated
Increases in Cyclic AMP Production in Nerve Cord and Corpus Cardiacum of
Periplaneta americana Corpus cardiacum ICW K, K, Antagonist (\>M) (\>M) (\iM) ...
Ivan Huber, Edward P. Masler, Balakrishna R. Rao, 1990
9
Aromatic Amino Acids in the Brain
concentrations. of. tryptophan. and. of. synthesis. of. 5-hydroxytryptamine. G. L.
GESSA and A. TAGLIAMONTE Institute of Pharmacology, University of Cagliari,
Cagliari Abstract Cerebral tryptophan hydroxylase is not saturated by the ...
CIBA Foundation Symposium, 2009
10
The Hormones V3: Physiology, Chemistry and Applications
Gaddum (131, 132) appears to have been the first to demonstrate an antagonism
between LSD and 5-hydroxytryptamine on certain isolated tissues and to suggest
that the action of LSD on the brain might be due to the blocking of normally ...
NNN Unknown Publisher, 1955
ȘTIRI NOI CARE INCLUD TERMENUL «HYDROXYTRYPTAMINE»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
hydroxytryptamine în contextul următoarelor știri.
Axovant Sciences Earns Outperform Rating from Analysts at Robert …
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «The Legacy, Iul 15»
Axovant Sciences' Quiet Period Will End on July 21st (NASDAQ …
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «sleekmoney, Iul 15»
Axovant Sciences Coverage Initiated at Robert W. Baird (AXON)
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «The Legacy, Iul 15»
Current Status of Co-Occurring Mood and Substance Use Disorders …
... randomized trial of sertraline for alcohol dependence: moderation by age of onset and 5-hydroxytryptamine transporter-linked promoter region genotype. «Focus, Iul 15»
Axovant Sciences Research Coverage Started at RBC Capital (AXON)
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «WKRB News, Iul 15»
Axovant Sciences Research Coverage Started at Evercore ISI (AXON)
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «The Legacy, Iul 15»
Evercore Partners Inc. Initiates Coverage on Axovant Sciences …
Its RVT-101 is an orally administered, potent antagonist of the 5-hydroxytryptamine 6 (NASDAQ:AXON) serotonin receptors in the brain. «sleekmoney, Iul 15»
Axovant Sciences to Present Data on RVT-101 at 2015 AAIC
RVT-101 is a potent, orally administered antagonist of the 5-hydroxytryptamine 6, or 5-HT6, serotonin receptors in the brain. Antagonism of the ... «Alzheimer's News Today, Iul 15»
How diet and physical activity affect brain function – Part II
BCAAs help the brain to produce protein, 5-HT (5-hydroxytryptamine or serotonin, is an important “brain messenger” and also combats ... «Health24, Iun 15»
Therapeutic antidepressant potential of a conjugated siRNA …
The midbrain serotonin (5-hydroxytryptamine (5-HT)) system has a critical role in many brain functions, including mood control. Derangements ... «Nature.com, Iun 15»
